...
首页> 外文期刊>MBio >A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis
【24h】

A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis

机译:用于有效基因组编辑的Crispr辅助的非肿瘤终结策略<命名含量含量 - 型=“属型”>分枝杆菌结核病

获取原文
   

获取外文期刊封面封底 >>

       

摘要

New tools for genetic manipulation of Mycobacterium tuberculosis are needed for the development of new drug regimens and vaccines aimed at curing tuberculosis infections. Clustered regularly interspaced short palindromic repeat (CRISPR)–CRISPR-associated protein (Cas) systems generate a highly specific double-strand break at the target site that can be repaired via nonhomologous end joining (NHEJ), resulting in the desired genome alteration. In this study, we first improved the NHEJ repair pathway and developed a CRISPR-Cas-mediated genome-editing method that allowed us to generate markerless deletion in Mycobacterium smegmatis , Mycobacterium marinum , and M. tuberculosis . Then, we demonstrated that this system could efficiently achieve simultaneous generation of double mutations and large-scale genetic mutations in M. tuberculosis . Finally, we showed that the strategy we developed can also be used to facilitate genome editing in Escherichia coli .
机译:新药方案和疫苗旨在治疗结核病感染的新药方案和疫苗所需的新型遗传操作工具。聚集经常间隙的短语重复(CRISPR) - 克里斯分泌的蛋白质(CAS)系统在靶位点产生高度特异性的双链断裂,其可以通过非汉语末端连接(NHEJ)来修复,导致所需的基因组改变。在这项研究中,我们首先改善了NHEJ修复途径,并开发了一种Casspr-Cas介导的基因组编辑方法,使我们在分枝杆菌,分枝杆菌和M.结核病中产生无价值缺失。然后,我们证明了该系统可以有效地达到在肺结核中同时产生双突变和大规模的遗传突变。最后,我们表明,我们开发的策略也可用于促进大肠杆菌中的基因组编辑。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号